Eli Lilly’s Obesity Drug Crunch Shows Signs of Easing in Japan

  • 📰 BNNBloomberg
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 50%

Finance Finance Headlines News

Finance Finance Latest News,Finance Finance Headlines

Eli Lilly & Co.’s hefty investment in expanding production capacity for its popular weight-loss and diabetes drugs is starting to pay off in Japan, allowing the company to lift shipment controls it imposed in the country last year.

Rite Aid CEO’s $20 Million Pay Spurs Bankruptcy Lender BacklashNomura’s Head of Markets Returns to Singapore After RevampRising US Debt Load Poses a Growing Risk for Treasury MarketSingapore Builder Oxley Seeks Up to $120 Million Private LoanYen Carry Trades Here to Stay as Overseas News Shrugged Off‘Everything Is Not Going to Be OK’ in Private Equity, Apollo’s Co-President SaysA Struggling Business Park Deals a Blow to Singapore's Regional Hub AmbitionsEncyclopaedia Britannica Seeks...

7 Billion in US Backing Sought by GOPChina Solar Giant Longi Alters Output as Sector Faces OversupplyCrypto Miner Riot Targeted by Short-Seller Kerrisdale on ‘Flawed’ Business ModelThe World Has Spent a ‘Shocking’ Full Year Breaking Heat RecordsHere are the key takeaways from Bank of Canada's rate-cut decisionTraders gird for weaker Canadian dollar as first rate cut eyedBank of Canada likely to cut rates: BermanRed tape and delays are holding back Canada’s productivity, Poloz and Manley...

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 83. in FİNANCE

Finance Finance Latest News, Finance Finance Headlines